Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enveric Biosciences Inc
(NQ:
ENVB
)
0.3256
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
July 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
July 15, 2022
Gainers
Via
Benzinga
Enveric Biosciences Reports Full-Year 2021 Financial Results
April 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 14, 2022
Via
Benzinga
Enveric Biosciences Announces Reverse Stock Split
July 14, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
July 13, 2022
Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the...
Via
Benzinga
Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio
July 13, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 12, 2022
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
June 30, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 28, 2022
Via
Benzinga
10 Psychedelics CEOs To Pay Attention To In 2022
June 22, 2022
By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
June 01, 2022
Upgrades
Via
Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
May 17, 2022
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 11, 2022
Via
Benzinga
EXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics
May 11, 2022
Enveric Biosciences (NASDAQ: ENVB), a biotech company working with cannabinoids and psychedelics, announced it will spin off its cannabinoid pipeline into a separate public company that will also be...
Via
Benzinga
American Billionaire Entrepreneurs Bet Millions on Psychedelics
May 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...
Via
FinancialNewsMedia
Exposures
Product Safety
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Roth Capital Reveals Top Psychedelic Picks in New Industry Report
April 21, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report...
Via
FinancialNewsMedia
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 20, 2022
Another day of trading is waiting for investors and we're kicking it off with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 19, 2022
Gainers
Via
Benzinga
EXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries
April 19, 2022
There were more than 30 different companies in the psychedelic space present at the inaugural Benzinga Psychedelics Capital Conference on Tuesday. But, Enveric is one of the only ones that offer...
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
April 18, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) shares rose 16.2% to $2.51 in pre-market trading. Mullen Automotive announced plans to begin construction for EV battery pack...
Via
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.
Via
Benzinga
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
April 04, 2022
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...
Via
Benzinga
New Research Reveals How Psychedelics Are Helping Combat Mental Illness
March 29, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily,...
Via
FinancialNewsMedia
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.